BVS

9.8800.70%
MP

Martin Paul Sutter

Independent Director

Mr. Martin Paul Sutter, also known as Marty, is Co-Founder, Managing Director, Director, President, Secretary and Founding Partner of Essex Woodlands Management, Inc. He joined the Essex Woodlands Management, Inc. in 1985. He is Independent Director at Bioventus Inc. since September 2020. He has been Independent Preferred Director at MiMedx Group, Inc. since July 2, 2020. Mr. Sutter has been directly involved with more than 30 of EW Healthcare Partners’ portfolio company investments. Mr. Sutter moved to Mitchell Energy & Development Corp. (MEDC) shortly thereafter. During his few years at MEDC, Mr. Sutter held various positions including Operations Analyst and Manager of Plant Operations. In 1984, Mr. Sutter founded and managed The Woodlands Venture Capital Company and in 1988, he formed The Woodlands Venture Partners. During his tenure at both firms, he founded and/or played a key role in the financing of several successful healthcare companies originating from various institutions of the world-renowned Texas Medical Center including Aronex Pharmaceuticals, Rgene, Amnion/Kardiothor and Zonagen. He was Co-Founder at Repros Therapeutics Inc. and Aronex Pharmaceuticals, Inc. He began his career in management consulting at Peat Marwick, Mitchell & Co. in 1977. He has served as a Director of ABIOMED Europe GmbH. Mr. Sutter serves on the Board of Directors of Xenex. He had been a Director of Abiomed, Inc. since May 2008 until December 22, 2022. He serves on the Board of Trustees of The Culinary Institute of America. He serves as a Member of Board of Managers at Xenex Disinfection Services. Mr. Sutter served as a member of the board of managers of Bioventus LLC since May 2012 and is its Director. He has been a Director of Prolacta Bioscience Inc. since December 6, 2016. Mr. Sutter serves also on the Board of the Texas Business Hall of Fame and a Member of the Biomedical Advisory Board of the Houston. Mr. Sutter served as the Chairman of Repros Therapeutics Inc. since December 1987 and Director since 1987. He served as Chairman of The Texas Lyceum. Mr. Sutter served as a Director of Suneva Medical, Inc. since August 4, 2016 until June 15, 2017. He served as Chairman of the Board of Directors of Aronex Pharmaceuticals, Inc. from 1986 to 1997. He served as Presiding Director of LifeCell Corporation and served as its Independent Director since December 22, 2003. Mr. Sutter served as a Director at BioForm Medical. Mr. Sutter served as a Director of Echo Therapeutics, Inc. from June 2002 to May 2004. He served as a Director of QSpex Technologies, Inc. from 2009 to 2017 and Medtronic ATS Medical, Inc. from December 2008 to August 12, 2010. Mr. Sutter has also previously served on the board of directors of Tissue Tech, Inc. He served as a Director of St. Francis Medical Technologies, Inc. since September 2006. He served as Director of La Jolla Pharmaceutical Co. from 2005 to September 3, 2009. He was also a Director of VitaGen, Inc., EluSys Therapeutics, Inc., MicroMed Cardiovascular Inc., Rinat Neuroscience Corp. and Confluent Surgical, Inc. He was Director of Cell Therapeutics Inc. since November 2002. Mr. Sutter was Director of Aronex Pharmaceuticals, Inc since June 1986. He was Lead Director at Merz Aesthetics, Inc. Mr. Sutter received B.S. degree in Chemical Engineering and Business Administration from Louisiana State University and holds an M.B.A. in Finance from the University of Houston.

Positions